NSDQ: ILMN

Hangzhou-based Glorious Med, a premier company specializing in gene detection for urinary system tumors, has entered into a partnership with US genomics giant Illumina (NSDQ: ILMN). The collaboration aims to advance the precise diagnosis of urinary tract pathogens and drug resistance genes through the use of Illumina’s Urinary Pathogen/Drug Resistance…